通过药剂师领导的患者教育改善心力衰竭的药物坚持:基于信息,动机和行为技能的机制研究协议
Tung-Chun Russell Chien1,2, Shao-En Weng3, Wan-Tseng Hsu1,2,4
1Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Patient preference and adherence
|July 2, 2025
概括
这项研究探讨了药剂师教育如何影响心力衰竭药物坚持使用信息-动机-行为技能模型. 这些发现将改进更好的患者坚持和结果的策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
- 患者坚持性研究
背景情况:
- 心力衰竭 (HF) 构成了全球健康的重大负担,药物不服药限制了指导方针导向医学治疗的有效性.
- 药剂师主导的患者教育越来越多地被认为是改善药物坚持的重要因素,但潜在的机制需要进一步研究.
- 了解这些机制对于开发有针对性的干预措施来提高长期高温管理结果至关重要.
研究的目的:
- 建立和评估一个信息-动机-行为技能 (IMB) 模型,解释HF患者的药物坚持.
- 为了比较干预前和干预后的IMB模型,以确定药剂师领导的患者教育显著影响的途径.
主要方法:
- 一个纵向的测试前后测试设计,通过在基线和3,6个月的验证患者报告结果测量 (PROMs) 来评估IMB构造.
- 将信息结构的口头查询和行为结构的处方补充数据纳入信息结构.
- 采用多组结构方程建模和潜在类增长建模来分析构造关系和坚持轨迹.
主要成果:
- 将评估药剂师干预前后IMB途径的结构变化.
- 识别短期和持续依赖的响应者.
- 了解患者教育如何影响与药物坚持相关的信息,动机和行为技能.
结论:
- 该研究预计将促进药剂师主导干预的精确准,以最大限度地提高HF管理中的临床影响.
- 结果将强调根据个体药物坚持概况量身定制医疗保健服务.
- 这项研究旨在优化药剂师领导的患者教育,以改善HF患者的治疗结果.
相关概念视频
Cardiomyopathy V: Interprofessional Care
40
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
40
Heart Failure VII: Nursing Interventions
147
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
147
Heart Failure V: Medical Management
33
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
33
Heart Failure VI: Adjunct Therapies
38
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
38
Cardiomyopathy VI: Nursing Management
47
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
47
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107


